Skip to content
POM-V Prescription Required Companion Animal

Quinoflox 100 mg/ml Solution for Use in Drinking Water for Chickens and Rabbits

Active ingredient: Enrofloxacin

Form

Solution

Species

Chickens Rabbits

Manufacturer

Global Vet Health S.L.

VMD MA No.

36167/4001

What it's used for

Rabbits: Treatment of respiratory infections caused by enrofloxacin. Amended pages: March 2026 AN: 02731/2024 & 02733/2024

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Enrofloxacin

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Quinoflox 100 mg/ml Solution for Use in Drinking Water for Chickens and Rabbits — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Rabbits: Treatment of respiratory infections caused by
enrofloxacin.

Amended pages: March 2026
AN: 02731/2024 & 02733/2024
10 mg enrofloxacin/kg bodyweight per day for 3-5 consecutive days.
Treatment for 3-5 consecutive days; for 5 consecutive days in mixed infections and
chronic progressive forms and rabbits. If no clinical improvement is achieved within
2-3 days, alternative antimicrobial therapy should be considered based on
susceptibility testing.
For the preparation of medicated water the body weight of the animals to be treated
and their actual daily water consumption should be taken into account. Consumption
may vary depending on factors like age, state of health, breed, husbandry system.
To provide the required amount of veterinary medicinal product in ml per litre
drinking water the following calculation should be made:
0.1ml of the veterinary
medicinal product per kg
bodyweight daily
x
average bodyweight
(kg) of the animals to
be treated
x
number
of
animals
Total water consumption (l) of the herd at the previous day
= ml of the
veterinary
medicinal product
per litre drinking
water
Sufficient access to the system of water supply should be available for the animals to
be treated to ensure adequate water consumption. No other source of drinking water
should be available during the medication period. Care should be taken that the
intended dose is completely ingested. Use appropriate and properly calibrated
dosing equipment.
If there is no clinical improvement within 3 days the treatment approach should be
reconsidered. After the end of the medication period the water supply system should
be cleaned appropriately to avoid intake of sub-therapeutic amounts of the active
substance which might support development of resistance.

Amended pages: March 2026
AN: 02731/2024 & 02733/2024
Medicated drinking water should be replaced every 24 hours.
Do not use in case of renal and hepatic failure.
Do not treat animals with cartilaginous growth disturbance.
Do not use in case of hypersensitivity to the active substance, other
(fluoro)quinolones or to any of the excipients.
Do not use when resistance/ cross-resistance to (fluoro)quinolones is known to occur
in the flock intended for treatment.
Chickens (Broilers, pullet, pullet future breeder, pullet for egg production future layer,
hen).
In young animals.
During the period of rapid growth.
Rabbits:
None known.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian,
to either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See also the package leaflet
for respective contact details.
Treatment of Mycoplasma spp. infections may not eradicate the microorganism.

Special precautions for safe use in the target species:
Do not use for prophylaxis.
Since enrofloxacin was first authorised for use in poultry, there has been widespread
reduction in susceptibility of to fluoroquinolones and emergence of resistant
organisms. Resistance has also been reported in Mycoplasma synoviae in the EU.
Official and local antimicrobial policies should be taken into account when the
product is used.
Where clinical experience, supported where possible by sensitivity testing of the
causal organism, indicates enrofloxacin as the drug of choice.
Fluoroquinolones should be reserved for the treatment of clinical conditions which
have responded poorly, or are expected to respond poorly, to other classes of
antimicrobials.
Wherever possible, fluoroquinolones should be used based on susceptibility testing.
Use of the veterinary medicinal product deviating from instructions given in the SPC
may increase the prevalence of bacteria resistant to fluoroquinolones and may
decrease the effectiveness of treatment with other quinolones due to the potential for
cross resistance.
After the end of treatment, the watering system should be cleaned appropriately to
prevent the intake of remaining subtherapeutic doses of the drug, which may lead to
resistance.
Before use, header tanks should be emptied, thoroughly cleaned and then filled with
a known volume of clean water before adding the required amount of veterinary
medicinal product. The resulting mixture should be stirred.
Before use, header tanks should be inspected at regular intervals for presence of
dust, algae formation and sedimentation.
If there is no clinical improvement within two to three days susceptibility testing
should be repeated and therapy should be changed, if appropriate.

Amended pages: March 2026
AN: 02731/2024 & 02733/2024
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
This veterinary medicinal product is an alkaline solution.
Personal protective equipment consisting of impervious gloves should be worn when
handling the veterinary medicinal product.
Direct contact with the skin should be avoided because of sensitisation, contact
dermatitis and possible hypersensitivity reactions.
In the event of eye or skin contact, rinse the affected area with clean water and if
irritation occurs, seek medical attention.
People with known hypersensitivity to (fluoro)quinolones should avoid contact with
the veterinary medicinal product.
Wash hands and exposed skin after use.
Do not eat, drink or smoke while handling the veterinary medicinal product.
Special precautions for the protection of the environment:
Not applicable.
Concurrent use of enrofloxacin with other antimicrobials, tetracyclines and macrolide
antibiotics, may result in antagonistic effects.
Absorption of enrofloxacin may be reduced if the veterinary medicinal product is
administered together with substances containing magnesium or aluminium.
Enrofloxacin may alter the hepatic metabolism of co-administered veterinary
medicinal products.
Do not administer with non steroidal anti-inflammatory products.
Protect from light.
Meat and offal:
Chickens: 7 days.
Rabbits: 2 days.
Do not use within 14 days before the start of the laying period.
Not for use in birds producing eggs for human consumption.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.